NCOA3 and cholangiocarcinoma: By reviewing literature, only Qiang Chen and his colleagues reported that down-regulation of AIB1 enhanced the sensitivity of tumor cells to cisplatin in cholangiocarcinoma 44, which is similar with our present result.